Clinical trial
Topical Ruxolitinib in the Treatment of Adults With Pyoderma Gangrenosum
NCT07783412 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Topical Ruxolitinib in the Treatment of Adults With Pyoderma Gangrenosum
- Lead sponsor
- Oregon Health and Science University
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- September 1, 2026
- Completion date
- December 31, 2029
- Enrollment
- 12 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.